Advertisement
U.S. markets open in 12 minutes

Krystal Biotech, Inc. (KRYS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
111.33-0.63 (-0.56%)
At close: 04:00PM EST
125.72 +14.39 (+12.93%)
Pre-Market: 09:18AM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/26/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
3.14B3.25B3.28B2.07B2.04B
Enterprise Value
2.59BN/AN/AN/AN/A
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
350.79N/AN/AN/AN/A
Price/Book (mrq)
4.155.016.713.953.77
Enterprise Value/Revenue
N/A324.73N/AN/AN/A
Enterprise Value/EBITDA
-16.52-110.40-79.51-47.59-30.95

Trading Information

Stock Price History

Beta (5Y Monthly) 0.76
52-Week Change 342.48%
S&P500 52-Week Change 327.79%
52 Week High 3133.60
52 Week Low 370.51
50-Day Moving Average 3118.90
200-Day Moving Average 3116.38

Share Statistics

Avg Vol (3 month) 3301.13k
Avg Vol (10 day) 3326.69k
Shares Outstanding 528.21M
Implied Shares Outstanding 628.21M
Float 820.35M
% Held by Insiders 113.57%
% Held by Institutions 190.01%
Shares Short (Jan 31, 2024) 42.03M
Short Ratio (Jan 31, 2024) 47.16
Short % of Float (Jan 31, 2024) 48.37%
Short % of Shares Outstanding (Jan 31, 2024) 47.19%
Shares Short (prior month Dec 29, 2023) 42.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sep 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-303.80%

Management Effectiveness

Return on Assets (ttm)-12.39%
Return on Equity (ttm)-4.60%

Income Statement

Revenue (ttm)8.56M
Revenue Per Share (ttm)0.32
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -131.81M
Net Income Avi to Common (ttm)-29.81M
Diluted EPS (ttm)-1.17
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)562.07M
Total Cash Per Share (mrq)19.93
Total Debt (mrq)8.32M
Total Debt/Equity (mrq)1.10%
Current Ratio (mrq)21.10
Book Value Per Share (mrq)26.81

Cash Flow Statement

Operating Cash Flow (ttm)-103.9M
Levered Free Cash Flow (ttm)-73.85M